Developing public health approaches to cognitive enhancement: An analysis of current reports

Public Health Ethics

Volumn 4, Issue 1, 2011, Pages 93-105

  Outram, Simon M ^a   Racine, Eric ^b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COGNITION; CONFERENCE PAPER; CONTENT ANALYSIS; HEALTH HAZARD; HEALTH SERVICE; HEALTH STATUS; HUMAN; MEDICAL DECISION MAKING; MEDICAL ETHICS; PERSONAL AUTONOMY; PRIORITY JOURNAL; PUBLIC HEALTH; RESPONSIBILITY; RISK BENEFIT ANALYSIS; SOCIAL ENVIRONMENT; SOCIOECONOMICS;

EID: 79952957103     PISSN: 17549973     EISSN: 17549981     Source Type: Journal    
DOI: 10.1093/phe/phr006     Document Type: Conference Paper

References (38)

1. Barrett, S. P., Darredeau, C., Bordy, L. E. and Pihl, R. O. (2005). Characteristics of Methylphenidate Misuse in a University Student Sample. Canadian Journal of Psychiatry, 50, 457-461. (Pubitemid 43161798)
2. Bayer, R. and Fairchild, A. L. (2004). The Genesis of Public Health Ethics. Bioethics, 18, 473-492. (Pubitemid 39425363)
3. Bostrom, N. and Sandberg, A. (2006). Cognitive Enhancement: Methods, Ethics and Regulatory Challenges. Oxford: Future of Humanity Institute, Oxford University [as referenced in BMA guideline].
4. Bostrom, N. and Sandberg, A. (2009). Cognitive Enhancement: Methods, Ethics, Regulatory Challenges. Science & Engineering Ethics, 15, 311-341.
5. Boyatzis, R. E. (1998). Transforming Qualitative Information: Thematic Analysis and Code Development. Thousand Oaks, CA: Sage Publications.
6. Briggs, D. J., Sabel, C. E. and Lee, K. (2009). Uncertainty in Epidemiology and Health Risk and Impact Assessment. Environmental Geochemistry and Health, 31, 189-203.
7. BMA. (2007). Boosting your Brainpower: Ethical Aspects of Cognitive Enhancement, available from http://www.bma.org.uk/images/Boosting-brainpower- tcm41-147266.pdf, [accessed 21 February 2011].
8. BMA. (1998). Health & Environmental Impact Assessment: An Integrated Approach. London: Earthscan.
9. Cakic, V. (2009). Smart Drugs for Cognitive Enhancement: Ethical and Pragmatic Considerations in the Era of Cosmetic Neurology. Journal of Medical Ethics, 35, 611-615.
10. Callahan, D. and Jennings, B. (2002). Ethics and Public Health: Forging a Strong Relationship. American Journal of Public Health, 92, 169-176. (Pubitemid 34101424)
11. CEST. (2009). Psychiatric Drugs and Expanded Uses: An Ethical Perspective, available from: Http://www.ethique.gouv.qc.ca/index.php?option=com- docman&Itemid=108 [accessed 21 February 2011].
12. Chatterjee, A. (2006). The Promise and Predicament of Cosmetic Neurology. Journal of Medical Ethics, 32, 110-113. (Pubitemid 43230583)
13. Childress, J. F., Faden, R. R., Gaare, R. D., Gostin, L. O., Kahn, J., Bonnie, R. J., Kass, N. E., Mastroianni, A. C., Moreno, J. D. and Nieburg, P. (2002). Public Health Ethics: Mapping the Terrain. The Journal of Law, Medicine, 30, 170-178. (Pubitemid 39273228)
14. Dawson, A. and Verweij, M. (2008). Public Health Ethics: A Manifesto. Public Health Ethics, 1, 1-2.
15. Farah, M. J., Illes, J., Cook-Deegan, R., Gardner, H., Kandel, E., King, P., Parens, E., Sahakian, B. and Wolpe, P. R. (2004). Neurocognitive Enhancement: What can we do and what should we do? Nature Reviews Neuroscience, 5, 421-425. (Pubitemid 38568502)
16. Godfrey, J. (2009). Safety of Therapeutic Methylphenidate in Adults: A Systematic Review of the Evidence. Journal of Psychopharmacology, 23, 194-205.
17. Greely, H., Sahakian, B., Harris, J., Kessler, R. C., Gazzaniga, M., Campbell, P. and Farah, M. J. (2008). Towards Responsible Use of Cognitive-Enhancing Drugs by the Healthy. Nature, 456, 702-705.
18. Hall, K. M., Irwin, M. M., Bowman, K. A., Frankenberger, W. and Jewett, D. C. (2005). Illicit Use of Prescribed Stimulant Medication Among College Students. Journal of American College Health, 53, 167-174. (Pubitemid 40139028)
19. Johnston, L. D., O'Malley, P. M., Bachman, J. G. and Schulenberg, J. E.(2008). Monitoring the Future National Survey Results on Drug Use, 1975-2007. Vol. II. College Students and Adults Ages 19-45 (NIH Publication No. 08-6418B). Bethesda, MD: National Institute on Drug Abuse, Table 2-2: 36, available from http://monitoringthefuture.org/pubs.html [accessed 21 February 2011].
20. Kass, N. E. (2001). An Ethics Framework for Public Health. American Journal of Public Health, 91, 1776-1782. (Pubitemid 33031731)
21. Kollins, S. H., MacDonald, E. K. and Rush, C. R. (2001). Assessing the Abuse Potential of Methylphenidate in Nonhuman and Human Subjects: A Review. Pharmacology Biochemistry and Behavior, 68, 611-627.
22. Kooij, J. J. S., Burger, H., Boonstra, A. M., Van Der Linden, P. D., Kalma, L. E. and Buitelaar, J. K. (2004). Efficacy and Safety of Methylphenidate in 45 Adults with Attention-Deficit/Hyperactivity Disorder. A randomized Placebo-Controlled Double-Blind Cross-Over Trial. Psychological Medicine, 34, 973-982. (Pubitemid 39199967)
23. Last, J. M. and International Epidemiological Association. (2001). A Dictionary of Epidemiology. New York: Oxford University Press.
24. Low, K. G. and Gendaszek, A. E. (2002). Illicit use of Psychostimulants Among College Students: A Preliminary Study. Psychology, Health & Medicine, 7, 283-287.
25. Mann, J. M. (1997). Medicine and Public Health, Ethics and Human Rights. The Hastings Center Report, 27, 6-13.
26. McCabe, S. E., Knight, J. R., Teter, C. J. and Wechsler, H. (2005). Non-Medical Use of Prescription Stimulants Among US College Students: Prevalence and Correlates from a National Survey. Addiction, 100, 96-106.
27. Munthe, C. (2008). The Goals of Public Health: An Integrated, Multidimensional Model. Public Health Ethics, 1, 39-52.
28. Outram, S. M. (2010). The Use of Methylphenidate Among Students: The Future of Enhancement? Journal of Medical Ethics, 36, 198-202.
29. Parens, E. (2005). Authenticity and Ambivalence. Hastings Center Report, 35, 34-41.
30. Racine, E. and Forlini, C. (2010). Cognitive Enhancement, Lifestyle Choice or Misuse of Prescription Drugs? Neuroethics, 3, 1-4.
31. Racine. (2010). Pragmatic Neuroethics: Improving Treatment and Understanding of the Mind-Brain. Cambridge: MIT Press.
32. Repantis, D., Schlattmann, P., Laisney, O. and Heuser, I. (2010). Modafinil and Methylphenidate for Neuroenhancement in Healthy Individuals: A Systematic Review. Pharmacological Research, 62, 187-206.
33. Rose, N. S. (2007). Politics of Life Itself: Biomedicine, Power, and Subjectivity in the Twenty-first Century. Princeton: Princeton University Press.
34. Sahakian, B. and Morein-Zamir, S. (2007). Professor's Little Helper. Nature, 450, 1157-1159.
35. Savulescu J. Justice, Fairness, and Enhancement. (2006). Annals of the New York Academy of Sciences, 1093, 321-338.
36. Teter, C. J., McCabe, S. E., Cranford, J. A., Boyd, C. J. and Guthrie, S. K. (2005). Prevalence and Motives for Illicit Use of Prescription Stimulants in an Undergraduate Student Sample. Journal of American College Health, 53, 253-262. (Pubitemid 40720541)
37. Tone, A. and Watkins, E. S. (2007). Medicating Modern America: Prescription Drugs in History. New York: New York University Press.
38. White, B. P., Becker-Blease, K. and Grace-Bishop, K. (2006). Stimulant Medication Use, Misuse, and Abuse in an Undergraduate and Graduate Student Sample. Journal of American College Health, 54, 261-268.